| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10735-011-9365-Z |
| P698 | PubMed publication ID | 22006287 |
| P2093 | author name string | Kunio Fujiwara | |
| Masashi Shin | |||
| Tsubasa Miyazaki | |||
| Tetsuya Saita | |||
| Yohei Yoshizaki | |||
| P2860 | cites work | Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney | Q77755736 |
| Distribution of anticancer antibiotic daunomycin in the rat heart and kidney revealed by immunocytochemistry using monoclonal antibodies | Q79931904 | ||
| The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology | Q28156073 | ||
| Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications | Q28379579 | ||
| Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake | Q33181593 | ||
| Expression of PEPT2 peptide transporter mRNA and protein in glial cells of rat dorsal root ganglia. | Q33181990 | ||
| Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects. | Q33990607 | ||
| Cellular and molecular aspects of drug transport in the kidney | Q34023104 | ||
| Peptide transporters in the intestine and the kidney | Q34063366 | ||
| Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes | Q34065254 | ||
| Inhibitors of leukotriene A4 (LTA4) hydrolase as potential anti-inflammatory agents | Q34224474 | ||
| Bestatin as an experimental tool in mammals | Q34314834 | ||
| The oligopeptide transporter (Pept-1) in human intestine: biology and function | Q34431100 | ||
| Immunocytochemistry for Amoxicillin and Its Use for Studying Uptake of the Drug in the Intestine, Liver, and Kidney of Rats | Q34483537 | ||
| Di/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and patho-physiological conditions. | Q35158253 | ||
| Biochemical and molecular pharmacological aspects of transporters as determinants of drug disposition | Q36108456 | ||
| Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney | Q37274759 | ||
| Review of ubenimex (Bestatin): clinical research | Q37362394 | ||
| Structural-functional relationship along the distal nephron | Q39735391 | ||
| The Analgesic Activity of Bestatin as a Potent APN Inhibitor | Q39856924 | ||
| Immunocytochemistry for drugs containing an aliphatic primary amino group in the molecule, anticancer antibiotic daunomycin as a model | Q40439716 | ||
| A monoclonal antibody against the glutaraldehyde-conjugated polyamine, putrescine: application to immunocytochemistry | Q40792232 | ||
| Monoclonal antibody against the glutaraldehyde-conjugated polyamine, spermine | Q42513519 | ||
| Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions | Q43893467 | ||
| Enzyme-linked immunosorbent assay for the quantification of actinomycin D using beta-D-galactosidase as a label | Q44039789 | ||
| PepT1 mRNA expression is induced by starvation and its level correlates with absorptive transport of cefadroxil longitudinally in the rat intestine | Q44211816 | ||
| Tubular localization and tissue distribution of peptide transporters in rat kidney | Q47678814 | ||
| Interaction of beta-lactam antibiotics with H+/peptide cotransporters in rat renal brush-border membranes | Q47723237 | ||
| The peptide transporter PepT2 mediates the uptake of the glutathione precursor CysGly in astroglia-rich primary cultures | Q47903468 | ||
| Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes. | Q48919944 | ||
| Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir | Q48932058 | ||
| Peptide mimics as substrates for the intestinal peptide transporter | Q48946712 | ||
| Functional characterization of the rat multispecific organic anion transporter OAT1 mediating basolateral uptake of anionic drugs in the kidney. | Q50741557 | ||
| H+ gradient-dependent and carrier-mediated transport of cefixime, a new cephalosporin antibiotic, across brush-border membrane vesicles from rat small intestine. | Q52428180 | ||
| H+ gradient-dependent transport of aminocephalosporins in rat renal brush border membrane vesicles: role of H+/organic cation antiport system | Q70081490 | ||
| Carrier-mediated transport of cephalexin via the dipeptide transport system in rat renal brush-border membrane vesicles | Q71269863 | ||
| Simultaneous determination of bestatin and p-hydroxybestatin, a major metabolite, in human serum by gas chromatography mass spectrometry. Utilization of quantitative selected ion monitoring and deuterium labelled internal standard | Q71506331 | ||
| Molecular mechanism for the relative binding affinity to the intestinal peptide carrier. Comparison of three ACE-inhibitors: enalapril, enalaprilat, and lisinopril | Q72344103 | ||
| Immunohistochemical localization of multispecific renal organic anion transporter 1 in rat kidney | Q74597815 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 589-596 | |
| P577 | publication date | 2011-10-18 | |
| P1433 | published in | Journal of Molecular Histology | Q2162212 |
| P1476 | title | Immunocytochemistry for bestatin and its application to drug accumulation studies in rat intestine and kidney | |
| P478 | volume | 42 |
Search more.